Updated January 13, 2021
1976
Avox (Acquired, Acriva) – Lightweight, battery-powered, portable blood analyzer, known as an oximeter, to measure oxygen, hemoglobin and other substances in blood and also useful for diagnosing problems, such as, heart defects.
1993
Osteobiologics (Acquired, 2006, Smith-Nephew) – Innovative bioabsorbable bone graft substitutes (BGS) to repair cartilage defects in the knee
1998
Vidacare (Acquired, 2013, Teleflex) – Patented power driver and needle system to access the intraosseous space for a variety of medical, diagnostic and therapeutic purposes. Vidacare’s proprietary devices are the recognized technology standard used in a broad range of applications including vascular access, emergency medicine, oncology, and spinal surgery.
1999
Advanced Bio ProSthetic, Ltd. – Palmaz cardiovascular stent
2001
Xenotope Diagnostics, Inc. – Develops novel solutions for global diseases through the implementation of its expertise in infectious disease research and unique discovery platform.
2004
Admittance Technologies – Innovative electrical engineering solutions
Cerebral Eidetics – Revoluntionary core-technology, image-guided, robotic transcranial magnetic stimulation (irTMS). irTMS is a “personalized medicine” individually mapping each patient’s brain connectome with functional MRI to create an optimized treatment plan.
2005
Cardio Spectra (Acquired, 2007, Volcano) – Innovative Optical Coherence Tomography (OCT) imaging technology for the diagnosis and treatment of diseases
Numira Biosciences, Inc. – High resolution MicroCT small animal imaging services
2010
Paragonix Technologies, Inc. – SherpaPakTM transport systems for donor organ preservation and transportation
2011
StemBioSys, Inc. – Enabling innovative regenerative medicine solutions with the novel High Performance Microenvironment (HPMETM) platform. Stem cell technologies for research and therapeutic pipelines
2012
Cardiovate, Inc. – Innovative devices for repair of cardiovascular conditions
Rapamycin Holdings (DBA, Emtora, Inc.) – Leveraging a platform of Rapamycin-related discoveries applicable to the veterinary and human markets. These discoveries could have dramatic implications in improving an individual’s health-span and in fighting age-related medical conditions.
2015
Astrocyte Pharmaceuticals, Inc. – Developing innovative neuroprotection therapies for traumatic brain injury (TBI), concussions, stroke, and neurodegenerative disorders
Digital Biopsy
Echolase, Inc. – Revolutionary acoustic sensor based on the patent pending probe beam deflection technology (PBDT)
NanoTX Therapeutics, Inc.
2017
GuadiumRX, LLC
Terrona
Vascular Perfusion Solutions, Inc.
Vindolar, LLC
2018
First Ascent Biomedical Corp
2019
Advanced Surgical Retractor Systems, Inc.
Anaxcel, LLC
Strong North Wind
2020
Atomic Therapeutics, Inc.
CardioVol
CereNovum, Inc.
EmergenceMed, LLC
Exprimon
HemaCure
Hera Biotech
InflammatoRX
Lonestar Sciences Inc.
Muen LLC
Novuprin
Protectum Oncology
Riverwalk Therapeutics, Inc.
SygnaMap, Inc.
Xtraction
Lonestar Sciences
Muen LLC
Tio Companies
NiRagen Inc.
2021
Pneumocyte LLC
Chymia, LLC
EtiraRx, Inc.
TD Pharma, LLC
2022
E3 Bioscience, LLC
Range Rehab
Keracruticals
SMIPRx
2023
Phage Refinery
Slick Health
VitaBone Medical
Oncobiomix
ProAllostera
Cogniphone